Ozone therapy uses ozone, a reactive form of oxygen, given as a gas injected into a joint or disc, mixed with drawn blood and returned, passed into the rectum, or applied to skin as ozonated oil. Controlled trials support only a few local uses. Injected into an arthritic knee, ozone eased pain more than a corticosteroid injection and about as well as hyaluronic acid; injected into a herniated disc it is linked to less back and leg pain; and added to diabetic foot ulcer care it sped healing and roughly halved amputations. Those trials are mostly small and low quality.
The broad selling points, that ozone detoxifies the body, raises its oxygen levels, or treats chronic disease across the board, are not established. Safety depends on the route: breathing ozone damages the lungs at any dose, and injecting the gas has caused gas embolism and stroke. The studied uses are local; the systemic cleanse claims need the most caution.
Findings & Outcomes
What It Is
Ozone therapy is the medical use of ozone, a reactive three-atom form of oxygen, delivered to the body in a limited dose and kept away from the airways. It is sold under many names and for many uses, from a gas injected into an arthritic knee to blood drawn, mixed with ozone, and returned to the body. The shared idea is that a small, controlled dose of a reactive gas prompts a mild adaptive response.
One word, ozone, covers treatments that differ in route, dose, evidence, and risk. A gas injected into a joint under imaging is a different proposition from a gas passed systemically, and both differ from breathing it, which is harmful.
Breathing ozone damages the lungs at any dose, and injecting the gas has caused gas embolism and stroke. Most of the risk comes down to the route and the dose.
Anatomy Of The Routes
1Intra-articular and local injection
A metered dose of oxygen-ozone gas is injected directly into a joint, most studied in the knee, or into or around a herniated spinal disc under imaging guidance. This is the route behind most of the pain evidence. Because it places gas into or near tissue and vessels, technique and imaging matter, and it carries the gas-embolism concern covered in the cautions.
2Autohemotherapy
In major autohemotherapy, a volume of blood is withdrawn, mixed with an ozone-oxygen mixture outside the body, and reinfused. This is the systemic route sold for fatigue, immunity, and chronic disease. Comprehensive safety data on this route remain limited.
3Rectal insufflation
An ozone-oxygen gas mixture is introduced into the rectum as a systemic route that avoids a vein. It appears in some diabetic-foot and systemic protocols. Dose control and technique matter here as with other gas routes into the body.
4Topical: ozonated water and oil
Ozone is dissolved into water or bubbled into a vegetable oil to make ozonated oil, then applied to skin or wounds. This is the gentlest route and the one behind some wound-care signals. It keeps the reactive chemistry at the surface, not in the bloodstream.
5Inhalation: the route to avoid
Breathing ozone gas is toxic. It is a lung irritant that reduces lung function and inflames the airways, so no protocol uses it. Legitimate ozone practice is built to keep the gas out of the breathing passages.
How It Works
The proposed mechanism is controlled oxidative eustress. A low, measured dose of ozone reacts briefly with blood and tissue to create a small burst of oxidative signaling, which is thought to switch on the body's own antioxidant defenses, chiefly the Nrf2 pathway and the enzymes it controls. This is the same hormetic principle behind exercise and heat: a mild, well-dosed stress prompts an adaptive response that leaves the system more resilient. For the underlying biology, see hormesis and inflammation.
The dose is what matters. The same molecule that may mildly signal at a low concentration is a potent oxidant and a toxin at higher ones, which is why the therapeutic dose must stay within a narrow window and why inhaling it is harmful. A preliminary human study reported that ozone preconditioning activated the Nrf2 antioxidant pathway, which keeps the mechanism plausible and under study. A pathway activating in a lab study is where the question starts. Whether a given condition improves is what trials have to answer, one use at a time.
The Selling Points And The Evidence
The marketing picture is expansive: ozone raises the body's oxygen, detoxifies it, and treats a broad range of chronic disease by stimulating the immune system. A person who acts on that is following a sales pitch that borrows the language of physiology.
The part with a basis is narrow. Two things are supported:
- An active, studied mechanism: a controlled oxidative signal that can switch on antioxidant defenses.
- A few local uses, in knee osteoarthritis, some wounds, and diabetic foot ulcers, where controlled trials show short-term signals, mostly at low quality.
Everything the broad market adds on top of that is a stretch. Ozone does not meaningfully raise the body's oxygen, whole-body detoxification is not an established effect, and the pooled trial evidence reaches only a few specific conditions. Some of the broadest claims have no plausible physiological basis. Set against this, ozone is a toxic gas to breathe, and certain injection routes carry a documented risk of gas embolism.
What The Research Shows
Knee Osteoarthritis
The knee has ozone's best evidence, and it is still emerging. Pooling the controlled trials, a meta-analysis found that an ozone injection into the joint reduced knee osteoarthritis pain more than a corticosteroid injection over the short and medium term, while cautioning that the underlying trials were low quality. A double-blind randomized trial of 59 people showed lower pain scores and better functional mobility, including walking distance, range of motion, and the Timed Up and Go test, against an oxygen-only control. Head to head, a level-I meta-analysis of 424 patients found ozone and hyaluronic acid injections gave similar pain relief at four to six months, with neither ahead.
The trials are small and short, concentrations and schedules vary, and the comparison is usually against another injection instead of a true placebo, so the size of the effect is not settled. The reasonable reading is a short-term pain option with early support, weighed against injections that have more evidence and clearer guideline standing.
Back And Disc Pain
For a herniated disc, an oxygen-ozone injection into or around the disc, sometimes called ozone discolysis, has a large but shaky evidence base. A meta-analysis pooling roughly 8,000 patients reported a mean pain drop of 3.9 on a 10-point scale and a 25.7-point improvement in disability, both above the threshold that patients notice, with a low reported complication rate.
The weakness is quality. The pooled studies were mostly uncontrolled or low quality, the analysis was retrospective, and industry affiliation was present, so the pooled figure sits above the true strength of the evidence. Read the disc result as a preliminary signal, and weigh it against the specific, if rare, risk of gas embolism when gas is injected near the spine, covered in the cautions.
Wounds And Diabetic Foot Ulcers
Wound care is the other area with short-term signals. Added to standard treatment, ozone therapy has been linked to faster healing of diabetic foot ulcers, shorter hospital stays, and a roughly halved amputation rate in a meta-analysis of 960 patients. The same analysis found ozone did not clearly improve the rate of complete ulcer resolution over good standard care, and a more recent umbrella review was more cautious still, finding the healing benefit not superior to control.
The reasonable summary: ozone may help as an add-on to proper diabetic wound care, most convincingly as topical ozonated oil or water, and not as a replacement for it. The amputation signal deserves clinical attention. A single older trial in people with type 2 diabetes also reported improved blood-sugar and antioxidant markers over twenty days, a preliminary lead and not a reason to use ozone for glucose control.
The Broad Detox And Chronic-Disease Claims
An umbrella review of the pooled randomized evidence found usable meta-analyses for only four conditions, with mixed or low-certainty results even there. For COVID-19, ozone lowered a laboratory test result but did not improve hospital stay, intensive-care admission, or survival. Nothing in the reviewed evidence supports whole-body detoxification, immune boosting, or treating chronic disease broadly, and several such claims have no plausible physiological basis. A lack of trial support does not make a specific effect impossible, but the sweeping detox and panacea claims are not established. This is the area where a reader is most likely to be oversold.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Pain
Ozone knee injection eased osteoarthritis pain at least as much as a steroid, and beat oxygen in a 59-person trial
An ozone shot into an arthritic knee eases pain in the short term about as much as a steroid shot does, in the trials done so far.
A 2026 systematic review and meta-analysis in Med Gas Res pooled controlled trials comparing intra-articular ozone with corticosteroid injection and found ozone gave greater pain reduction than corticosteroid over the short and medium term, while cautioning that the underlying trials were low quality and that only steroid and hyaluronic acid are guideline-recommended. A separate 2025 double-blind randomized trial (Adv Rheumatol, n=59, NCT06088706) gave weekly ozone at 20 or 40 micrograms per milliliter for four weeks and saw significant falls in visual-analogue pain scores versus an oxygen control, with no difference between the two ozone doses. The trials are small, short, and use varied concentrations and schedules.
Any benefit measured so far is short-term. If someone is weighing an ozone knee injection, the fair comparison is against steroid or hyaluronic acid injections that have more evidence and clearer guideline standing.
The studies · 2
Arias-Vazquez et al., ozone injections reduce pain in knee osteoarthritis · Med Gas Res 2026;16(3):286-292
Arjmanddoust et al., two doses of intra-articular ozone therapy in knee osteoarthritis, double-blind RCT · Adv Rheumatol 2025;65(1):11
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Oxygen-ozone disc injection tied to a 3.9-point pain drop across roughly 8,000 herniated-disc patients, in mostly low-quality studies
For a herniated disc, injecting an oxygen-ozone mix into or around the disc was linked to meaningfully less back and leg pain in a large pooled analysis, though the underlying studies were mostly low quality.
The 2010 J Vasc Interv Radiol meta-analysis pooled twelve studies covering almost 8,000 patients treated with oxygen-ozone for herniated lumbar discs. Mean improvement was 3.9 points on the visual-analogue scale and 25.7 points on the Oswestry Disability Index, both above the minimum clinically important difference, with a modified MacNab improvement likelihood of 79.7 percent and a low pooled complication rate. The included studies were largely uncontrolled or low quality, the analysis was retrospective, and a lead author was affiliated with an ozone-device company, so the pooled figure sits above the true strength of the evidence.
The large patient numbers are attractive, but they come mostly from uncontrolled studies. Read the disc result as a preliminary signal, and weigh it against the documented, if rare, risk of gas embolism from injecting near the spine, covered in the cautions.
The study · 1
Steppan et al., meta-analysis of ozone treatment for herniated lumbar discs · J Vasc Interv Radiol 2010;21(4):534-548
Joint And Arthritis Pain
In the same 59-person trial, ozone improved knee function, range of motion and six-minute walk distance
Alongside less pain, people in the trial moved a bit better: they walked further and got up and moving more easily than the control group.
The 2025 Adv Rheumatol randomized controlled trial (n=59, three arms: ozone 20 micrograms per milliliter, 40 micrograms per milliliter, and oxygen control) reported significant gains in functional-mobility measures for both ozone arms versus control, including the WOMAC function subscale, knee flexion range of motion, the Timed Up and Go test, and the six-minute walk test, with no significant difference between the two ozone concentrations. Follow-up was short and the sample was small.
The mobility gains ride alongside the pain result from one small trial. Treat them as an early signal worth watching, not a settled functional benefit, and keep loading exercise as the intervention with the strongest evidence for knee osteoarthritis function.
The study · 1
Arjmanddoust et al., two doses of intra-articular ozone therapy in knee osteoarthritis, double-blind RCT · Adv Rheumatol 2025;65(1):11
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Ozone matched hyaluronic acid for knee pain, with no difference across 424 patients
Head to head, ozone and hyaluronic acid knee injections gave about the same pain relief a few months out, with neither pulling ahead.
A 2024 level-I meta-analysis (Eur J Orthop Surg Traumatol) collected data on 424 patients (74 percent women, mean age 61) comparing intra-articular ozone with hyaluronic acid. Groups were matched on age, BMI and baseline patient-reported outcomes, and there was no significant difference in visual-analogue pain scores at four to six months (P = 0.4). The finding is that the two are comparable, not that either is inert.
If a clinic frames ozone as clearly better than the established hyaluronic-acid injection, the head-to-head evidence does not support that; they performed similarly in the pooled data.
The study · 1
Migliorini et al., intra-articular ozone versus hyaluronic acid for knee osteoarthritis, level I meta-analysis · Eur J Orthop Surg Traumatol 2024;35(1):20
Skin And Hair
As an add-on for diabetic foot ulcers, ozone roughly halved amputations (RR 0.46) but did not close more ulcers
For diabetic foot ulcers, adding ozone to normal wound care sped healing and lowered the chance of amputation, but it did not clearly make more ulcers close completely than good standard care by itself.
A 2024 systematic review and meta-analysis (Curr Pharm Des) of eleven studies and 960 patients found ozone as an adjunct significantly shortened mean healing time and hospital stay and reduced amputation risk (RR 0.46, 95 percent CI 0.30 to 0.71), while noting its effect did not differ from standard treatment for complete ulcer resolution. A 2026 umbrella review of meta-analyzes reached a more cautious conclusion, finding ozone not superior to control for ulcer healing (RR 1.69, 95 percent CI 0.90 to 3.17, the interval crossing no effect). Heterogeneity between studies is high.
The most reliable reading is that ozone may help as an add-on to proper diabetic wound care, not as a replacement for it. The amputation signal is worth clinical attention, and the complete-healing benefit is not established.
The study · 1
Izadi et al., ozone therapy on diabetes-related foot ulcer outcomes, systematic review and meta-analysis · Curr Pharm Des 2024;30(27):2152-2166
Blood Sugar
In one 101-patient trial, twenty days of ozone improved blood-sugar and antioxidant markers
One older trial in diabetic patients found a course of ozone nudged blood sugar and antioxidant markers in a favorable direction, but it is a single small study.
A 2005 randomized controlled trial (Eur J Pharmacol) in Havana enrolled 101 patients with type 2 diabetes and neuroinfectious diabetic foot, giving one group ozone by local and rectal insufflation and the other topical and systemic antibiotics for twenty days. The ozone group showed improved glycemic control, prevented oxidative stress with normalized organic peroxides, and increased superoxide-dismutase activity. It is one small, short, single-center trial, not replicated at scale, and the metabolic changes are secondary to a wound-treatment study rather than a dedicated glucose-control trial.
This is a preliminary signal from one small study, not a reason to consider ozone for blood-sugar control. Approaches with far stronger evidence, such as diet, exercise, and glucose-lowering medication, remain the better choice.
The study · 1
Martinez-Sanchez et al., therapeutic efficacy of ozone in patients with diabetic foot · Eur J Pharmacol 2005;523(1-3):151-161
How it works
The oxidative-eustress idea: a low ozone dose may switch on Nrf2 antioxidant defenses, a mechanism not a proven benefit
The idea behind ozone is a small, controlled dose of oxidative stress that prompts the body to raise its own antioxidant defenses, and an early study saw signs of that response.
The hormetic hypothesis holds that a low ozone dose produces a brief, controlled oxidative stress (eustress) that upregulates the Nrf2 and electrophile-responsive-element pathway and downstream antioxidant enzymes. A 2014 preliminary in-vivo study (Eur J Pharmacol) in healthy volunteers receiving three major autohemotherapy sessions reported evidence linking ozone preconditioning to Nrf2 or EpRE activation. This is a plausible, actively-studied mechanism, and a moving mechanistic marker does not establish that any clinical outcome improves. Dose is central: the same molecule that mildly signals at low concentration is a toxin at higher ones.
Read the mechanism as a hypothesis under study, not as evidence of benefit. A pathway activating in a lab study is where the question starts; whether ozone helps a given condition is what a trial has to show.
The study · 1
Re et al., is ozone pre-conditioning linked to the Nrf2/EpRE pathway in vivo, preliminary result · Eur J Pharmacol 2014;742:158-162
Evidence And Methods
The broad detox and chronic-disease claims are not established; pooled trials reach only four conditions
The sweeping claims that ozone detoxifies the body or treats a broad range of chronic disease are not backed by the pooled trial evidence, which reaches only a handful of specific conditions and is mixed even there.
A 2026 umbrella review (Med Sci, Basel) of systematic reviews with meta-analyzes of randomized trials found only seven meta-analyzes covering four indications: chronic periodontitis (mixed), COVID-19, diabetic foot ulcers, and impacted third-molar surgery. For COVID-19, ozone reduced PCR positivity (RR 0.07) but this was judged a clinically unimportant surrogate, with no benefit for hospital stay, ICU admission or mortality. Certainty of evidence by GRADE was generally low. Nothing in the reviewed evidence supports systemic detoxification, immune boosting, or treating chronic disease broadly, and some such claims lack a plausible physiological basis.
When a clinic offers ozone for a long list of unrelated chronic conditions or for detoxification, the pooled evidence does not reach those uses. Ask which specific condition has trial evidence, and at what certainty.
The study · 1
Cacciatore et al., effectiveness and safety of ozone therapy in humans, umbrella review · Med Sci (Basel) 2026;14(2):289
The Regulatory Position
Regulators treat ozone with unusual bluntness. The United States Food and Drug Administration states that ozone is a toxic gas with no known useful medical application in general medicine, and that for ozone to work as a germicide it must be present at a concentration far greater than can be safely tolerated by people and animals. The agency has acted against devices marketed to introduce ozone into the body.
That position sits alongside the specific trial evidence: a few local uses carry early signals, and the broad medical claims for ozone are not accepted by regulators. Anyone weighing ozone therapy is doing so as an option that lacks general regulatory approval.
Go Deeper
- IV vitamin drips and NAD therapy: another infusion category sold in storefronts, where the delivery is dramatic and the promise is far ahead of the controlled evidence.
- Hyperbaric oxygen: a different oxygen-based therapy, useful for seeing where a gas-delivery treatment has firm evidence for specific uses and where it does not.
- Arthritis: the joint condition where ozone has its strongest signal, set against the other options for knee pain.
- Low back pain: the wider picture for disc and back pain, into which the ozone discolysis evidence fits.
- Red light therapy: another device-based practice, useful for comparing how evidence and marketing diverge.
The Chinese Medicine View
Ozone therapy is a product of modern chemistry and medicine, with no entry in the classical Chinese pharmacopoeia. No historical text assigns ozone a channel, a temperature, or a flavor, and no traditional preparation resembles it. This places the practice against the tradition as a lens, not as evidence, and it borrows no classical claim, because none exists.
The tradition does reason about the territory the therapy aims at. The hormetic idea behind ozone, a small controlled stress that prompts the body to strengthen its own defenses, sits close to the classical teaching that the body heals by restoring its own balance. A central principle is that vitality is cultivated by supporting the body's own capacity, and that pushing a system harder than its nature allows tends to cause harm. Through that lens, a low, carefully judged dose that prompts an adaptive response is intelligible, while a strong oxidative load would be the kind of forcing the tradition cautions against. A careful practitioner would also weigh the individual: the same intervention that suits one constitution may not suit another, and appropriateness is judged case by case.
This connects a modern practice to a framework the tradition has reasoned about for a long time. It is not a claim that Chinese medicine endorses or explains ozone therapy. The concepts belong to the tradition as it uses them, and the evidence for any ozone use stands or falls on the trials.
Cautions For This Practice
Everything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Breathing ozone at just 0.07 ppm cut lung function and inflamed the airways of 38 healthy adults
A 2026 double-blind randomized controlled human exposure study (Environ Res) exposed 38 healthy adults aged 19 to 34 to clean air and to 0.07 ppm ozone for 6.6 hours with intermittent moderate exercise, measuring pulmonary function before and after and neutrophils in sputum. Ozone at this low, regulatory-standard concentration produced decremental lung-function effects and airway inflammation. The authors note that controlled human exposure studies have consistently provided strong evidence of harmful respiratory effects of ozone, a body of work underpinning air-quality regulation. Clinical ozone routes are deliberately designed to keep the gas away from the airways for exactly this reason.Pennington et al., lung function and inflammation after 6.6 hours of 0.07 ppm ozone exposure
Injected ozone has caused gas embolism and multifocal stroke, in one case through a heart defect (patent foramen ovale)
Multiple case reports document serious gas-embolic events from ozone injection. A 2024 report (BMJ Neurol Open) describes a 58-year-old woman who developed multiple cerebral gas emboli and multifocal ischemic stroke during an intradiscal oxygen-ozone injection for disc herniation, with echocardiography revealing a patent foramen ovale as a route for paradoxical embolism. A further report describes multifocal stroke from ozone gas emboli following a cervical paravertebral ozone injection. These are individual cases rather than pooled incidence, so they establish that the harm is real and can be severe, without fixing how often it happens.Khosravi and Mirzaasgari, cerebral gas embolism and multifocal ischemic stroke during oxygen-ozone therapyMultifocal stroke from ozone gas emboli, case report
Ozone autohemotherapy's safety record is too thin to quantify its true side-effect rate
A 2026 PRISMA-guided scoping review (Clin Exp Rheumatol) of oxygen-ozone autohemotherapy, focused on fibromyalgia, set out to catalog documented adverse events and stratify risk, and concluded that comprehensive safety data remain limited despite growing clinical interest. This is a statement about the state of the evidence rather than a measured harm rate: the systemic route is used without a well-characterized adverse-event profile, which itself is a reason for caution and for treatment only in properly equipped settings.Casale et al., oxygen-ozone autohaemotherapy in fibromyalgia, safety profile and adverse events, scoping review
Inhaling ozone is harmful
Ozone is a respiratory toxin. Controlled human exposure shows that even at the low concentration allowed for outdoor air, breathing it reduces lung function and inflames the airways of healthy adults. No protocol treats inhalation as a route, and legitimate ozone practice is designed to keep the gas out of the breathing passages.
Gas embolism from injected ozone
Because ozone is delivered as a gas, injecting it can introduce bubbles into the bloodstream. Case reports describe cerebral gas embolism and multifocal stroke during intradiscal and cervical paravertebral (neck) ozone injection, in one case through a patent foramen ovale, a common heart opening that lets a bubble cross to the arterial side. Injecting ozone into a vein is a separate and serious danger for the same reason. This is why the intravenous and intradiscal routes raise the most concern, and why imaging and technique matter for spinal injection.
Systemic routes have limited safety data
For autohemotherapy and other systemic routes, comprehensive adverse-event data remain limited, so the true risk profile is not well characterized even where the treatment is in use. Thin documentation is not the same as demonstrated safety. That gap is a reason for conservative use and for treatment only in a properly equipped setting.
Unregulated clinics and no general approval
The United States Food and Drug Administration considers ozone a toxic gas with no known useful general medical application, and ozone therapy lacks general regulatory approval. Many treatments are offered in storefront or clinic settings outside standard medical checks, so dosing, sterile technique, screening, and emergency readiness are not guaranteed. Before any course, a fair question is which specific use has trial evidence, and at what certainty.
Not a substitute for diagnosis or standard care
Where ozone shows signals, such as diabetic foot ulcers, it is as an add-on to proper wound care, not a replacement for it. Reaching for ozone to treat a serious or persistent condition can delay finding and treating the underlying cause. For a condition that matters, the sound path is a diagnosis and standard care first, with any ozone use discussed against that.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Does ozone therapy work for anything?
For a few local uses, the evidence shows short-term signals. Injecting ozone into an arthritic knee eased pain more than a steroid injection in the trials so far, and adding ozone to standard diabetic foot-ulcer care has been linked to faster healing and fewer amputations. These results are mostly small, short, and of low to moderate quality. Beyond that handful of uses, the pooled trial evidence thins out fast, and the broad claims that ozone detoxifies the body or treats a wide range of chronic disease are not established.
Is ozone therapy safe?
It depends almost entirely on the route. Breathing ozone is harmful, since it is a lung toxin, so inhalation is not a treatment route at all. Injecting the gas carries a documented risk of gas embolism, with case reports of cerebral emboli and stroke during disc and neck injections. Injecting it into a vein is a separate, serious danger, which makes the intradiscal and intravenous routes the ones of greatest concern. Topical ozonated oil or water keeps the chemistry at the surface and is the gentlest option. For systemic routes such as autohemotherapy, comprehensive safety data are limited, so the risk profile is not well characterized. Route, dose, and the quality of the setting account for most of the safety.
What does the FDA say about ozone therapy?
The United States Food and Drug Administration states that ozone is a toxic gas with no known useful medical application in general medicine, and that any germicidal effect requires concentrations unsafe for people. Ozone therapy lacks general regulatory approval, and the agency has acted against devices marketed to introduce ozone into the body. That regulatory position sits alongside the specific research: a few local uses carry early trial signals, while the broad medical claims are not accepted.
Does ozone detoxify the body or boost oxygen levels?
The evidence does not support this. Ozone does not meaningfully raise the body's oxygen, and whole-body detoxification is not an established effect. The mechanism under study is narrower: a low, controlled dose may act as a mild oxidative signal that switches on the body's own antioxidant defenses. That is a plausible, actively-researched idea, and a long way from the claim that ozone cleanses the body or raises its oxygen.
How is ozone therapy given?
By several routes that differ a great deal. A metered gas can be injected into a joint or near a spinal disc under imaging. In autohemotherapy, blood is withdrawn, mixed with ozone outside the body, and returned. Rectal insufflation introduces the gas mixture without using a vein. Ozonated water and oil are applied to skin and wounds. Each route carries its own evidence and its own risk, so a single verdict on ozone therapy is less useful than looking at the specific route and use in front of you.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 13 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.